Trials / Unknown
UnknownNCT00215007
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With Levofloxacin as Prophylaxis for Bacterial Infections in Immunocompromised Patients After Allogeneic Transplantation of Hematopoietic Stem Cells
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levofloxacin |
Timeline
- First posted
- 2005-09-22
- Last updated
- 2007-11-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00215007. Inclusion in this directory is not an endorsement.